Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Vintafolide +/- Docetaxel in 2nd Line FR(++) NSCLC
NCT01577654Phase 2Completed
- Sponsor
- Endocyte
- Start
- Mar 2011
- Primary completion
- Dec 2013
- Modality
- Prodrugs/Conditional Activator Small Molecules, Peptide-Drug Conjugates
01
Overview
A Phase 2 trial of vintafolide in non-small cell lung cancer (NSCLC), sponsored by Endocyte. Started Mar 2011; status: completed.
02
Drugs
vintafolide
03
Conditions
non-small cell lung cancer (NSCLC)
Beyond the preview
Go deeper on NCT01577654.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01577654.